menu
    • menu

    Company profile for Clearmind Medicine

    NEW Drugs in Dev: 4
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Clearmind Medicine (CSE: CMND) develops novel psychedelic medicines to solve widespread, yet under-served, health problems. With a strong medical management team and IP-protection, we can better the lives of millions. With a clear focus on alcohol abuse and binge drinking, Clearmind's first drug candidate addresses very common (and costly) afflictions which to date, have limited solutions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Clearmind MedicineCanada Flag
    Country
    Country
    Canada
    Address
    Address
    101 – 1220 W 6 Ave Vancouver, BC V6H1A5
    Telephone
    Telephone
    (778) 400 5347
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.clearmindmedicine.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/clearmind-medicine/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Clearmind Medicine Completes Phase I/IIa Trial For CMND-100
    Clearmind Medicine Completes Phase I/IIa Trial For CMND-100

    14 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/14/3218685/0/en/Clearmind-Medicine-Announces-Successful-Completion-of-Treatment-in-All-Patients-of-the-Second-Cohort-in-Ongoing-Phase-I-IIa-Clinical-Trial-for-CMND-100.html

    GLOBENEWSWIRE
    14 Jan 2026
    Share Share
    Clearmind Medicine Restores Nasdaq Minimum Bid Price Compliance
    Clearmind Medicine Restores Nasdaq Minimum Bid Price Compliance

    31 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/31/3211807/0/en/Clearmind-Medicine-Regains-Compliance-with-Nasdaq-Minimum-Bid-Price-Requirement.html

    GLOBENEWSWIRE
    31 Dec 2025
    Share Share
    Clearmind Medicine Advances Clinically, Expands Globally
    Clearmind Medicine Advances Clinically, Expands Globally

    24 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/24/3210333/0/en/Clearmind-Medicine-Reflects-on-a-Transformative-2025-Key-Clinical-Advancements-Expanded-Global-Reach-and-Strengthened-Foundation-for-Future-Growth.html

    GLOBENEWSWIRE
    24 Dec 2025
    Share Share
    Clearmind Medicine Finishes FDA Phase I/IIa Cohort 2 for MEAI
    Clearmind Medicine Finishes FDA Phase I/IIa Cohort 2 for MEAI

    16 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/16/3206246/0/en/Clearmind-Medicine-Announces-Successful-Completion-of-Second-Cohort-Enrollment-in-Ongoing-FDA-Approved-Phase-I-IIa-Trial-for-CMND-100.html

    GLOBENEWSWIRE
    16 Dec 2025
    Share Share
    Clearmind Pharma Restores Nasdaq Stockholders' Equity Compliance
    Clearmind Pharma Restores Nasdaq Stockholders' Equity Compliance

    12 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/12/3204542/0/en/Clearmind-Medicine-Successfully-Regains-Compliance-with-Nasdaq-s-Minimum-Stockholders-Equity-Requirement.html

    GLOBENEWSWIRE
    12 Dec 2025
    Share Share
    Clearmind Medicine's MEAI Spotlighted in Prestigious Review
    Clearmind Medicine's MEAI Spotlighted in Prestigious Review

    12 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/12/3204638/0/en/Clearmind-Medicine-s-MEAI-Spotlighted-in-Prestigious-Review-Leading-Experts-Affirm-Transformative-Potential-for-Alcohol-Use-Disorder-Treatment.html

    GLOBENEWSWIRE
    12 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search